Target intelligence / Profile preview

Zea mays inositol-pentakisphosphate 2-kinase 1 (ZmIpk1) (ZmIpk1)

Target
ZmIpk1
Molecular classification
Enzyme, Kinase, Inositol phosphate kinase, Transferase
01

Overview

Zea mays inositol-pentakisphosphate 2-kinase 1 (ZmIpk1) is a critical enzyme in the phytic acid (inositol hexakisphosphate, IP6) biosynthetic pathway in maize (Sun et al., 2007). It catalyzes the final phosphorylation step, converting inositol-1,3,4,5,6-pentakisphosphate into IP6, which is the primary storage form of phosphorus in seeds (UniProt B4F9Y1). From a biotechnological perspective, ZmIpk1 is a major target for the development of low phytic acid (lpa) crops. Phytic acid is an anti-nutrient that chelates essential minerals like iron and zinc, reducing their bioavailability in humans and monogastric animals (Li et al., 2018). Furthermore, high levels of phytic acid in animal feed lead to excessive phosphorus excretion, contributing to environmental eutrophication. While no human therapeutic drugs currently target ZmIpk1, it is a primary focus for genetic engineering and CRISPR-Cas9 strategies aimed at improving grain nutritional quality and environmental sustainability (Shukla et al., 2004). The enzyme's activity is essential for phosphorus homeostasis, but its reduction is sought to enhance the nutritional profile of staple crops.

Other names
ZmIPK1Inositol-pentakisphosphate 2-kinase 1IPK1Zea mays IPK1Zm00001d033716
02

Mechanism of action

Catalytic conversion of inositol-1,3,4,5,6-pentakisphosphate to inositol hexakisphosphate (phytic acid) via phosphorylation.

03

Biological functions

Phytic acid biosynthesisInositol phosphate metabolismPhosphorus storageMineral homeostasis
04

Disease associations

Micronutrient deficiencyMalnutritionEnvironmental phosphorus pollution
05

Safety considerations

Reduced seed germination ratesDecreased plant stress tolerancePotential impact on seed development
06

Biomarkers

Seed phytic acid levelsInorganic phosphorus contentMineral bioavailability

Beyond the preview

Go deeper on Zea mays inositol-pentakisphosphate 2-kinase 1 (ZmIpk1) (ZmIpk1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zea mays inositol-pentakisphosphate 2-kinase 1 (ZmIpk1) (ZmIpk1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call